GENE SOLUTIONS (UK) LTD

Active London

Other research and experimental development on natural sciences and engineering

0 employees website.com
Other research and experimental development on natural sciences and engineering
G

GENE SOLUTIONS (UK) LTD

Other research and experimental development on natural sciences and engineering

Founded 16 Apr 2014 Active London, United Kingdom 0 employees website.com
Other research and experimental development on natural sciences and engineering
Accounts Submitted 2 Apr 2026 Next due 31 May 2026 13 days overdue
Confirmation Submitted 20 Apr 2026 Next due 30 Apr 2027 10 months remaining
Net assets £-5M £167K 2025 year on year
Total assets £45K £830 2025 year on year
Total Liabilities £5M £168K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

10 John Street London WC1N 2EB United Kingdom

Full company profile for GENE SOLUTIONS (UK) LTD (08999306), an active company based in London, United Kingdom. Incorporated 16 Apr 2014. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Sept → 31 Aug 2025
Type total-exemption-full
Next accounts 31 Aug 2025
Due by 31 May 2026 1 month overdue

Net Assets, Total Assets & Total Liabilities (2014–2025)

Cash in Bank

£43.77k

Decreased by £765.00 (-2%)

Net Assets

-£4.52M

Decreased by £167.48k (-4%)

Total Liabilities

£4.56M

Increased by £168.31k (+4%)

Turnover

N/A

Employees

N/A

Debt Ratio

10027%

Increased by 190 (+2%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Aug Year End
2024
31 Aug Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

3 active
Status
Connell, Edward PhilipDirectorAmericanUnited States7616 Apr 2014Active
Oury, James EdwardDirectorBritishUnited States5729 May 2014Active
Patteson, David BlairDirectorAmericanUnited States7016 Apr 2014Active

Shareholders

Shareholders (3)

Gene Solutions Llc
100.0%
903
James Edward Oury
0.0%
0

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
20 Apr 2026Confirmation StatementConfirmation statement made on 16 Apr 2026 with updates
2 Apr 2026AccountsAnnual accounts made up to 31 Aug 2025
8 Dec 2025OfficersTermination of Brian Herbert as director
16 Jul 2025AccountsAnnual accounts made up to 31 Aug 2024
13 May 2025OfficersTermination of Brian Herbert Warrington as director on 28 Mar 2025
20 Apr 2026 Confirmation Statement

Confirmation statement made on 16 Apr 2026 with updates

2 Apr 2026 Accounts

Annual accounts made up to 31 Aug 2025

8 Dec 2025 Officers

Termination of Brian Herbert as director

16 Jul 2025 Accounts

Annual accounts made up to 31 Aug 2024

13 May 2025 Officers

Termination of Brian Herbert Warrington as director on 28 Mar 2025

Recent Activity

Latest Activity

Confirmation statement made on 16 Apr 2026 with updates

1 months ago on 20 Apr 2026

Annual accounts made up to 31 Aug 2025

2 months ago on 2 Apr 2026

Termination of Brian Herbert as director

6 months ago on 8 Dec 2025

Annual accounts made up to 31 Aug 2024

11 months ago on 16 Jul 2025

Termination of Brian Herbert Warrington as director on 28 Mar 2025

1 years ago on 13 May 2025